36.67
price up icon3.38%   1.20
after-market Handel nachbörslich: 36.67
loading

Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten

pulisher
12:38 PM

Mizuho Lifts Harmony Biosciences Target to $50, Citing Confidence in Fragile X Trial - Insider Monkey

12:38 PM
pulisher
06:56 AM

Harmony Biosciences Holdings Inc. Stock Poised for Technical ComebackJuly 2025 Patterns & Verified Momentum Stock Ideas - 선데이타임즈

06:56 AM
pulisher
Aug 12, 2025

Harmony Biosciences Delivers Strong Q2 Growth, Advances Late-Stage Pipeline - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

H.C. Wainwright Remains a Buy on Harmony Biosciences Holdings (HRMY) - Insider Monkey

Aug 12, 2025
pulisher
Aug 11, 2025

Mizuho raises Harmony Biosciences stock price target to $50 on increased confidence - Investing.com Australia

Aug 11, 2025
pulisher
Aug 11, 2025

Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $50 at Mizuho - StreetInsider

Aug 11, 2025
pulisher
Aug 10, 2025

Relief Rally in Harmony Biosciences Holdings Inc. Stock — Can It HoldEarly Entry Tips With Low Risk Zone Shared - beatles.ru

Aug 10, 2025
pulisher
Aug 07, 2025

SIXS ETF Implied Analyst Target Price: $58.24 - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Earnings Call Highlights Growth and Innovation - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Inc: A Financial Analysis of Growth and Strategic Positioning - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Reports Strong Q2 Revenue Growth, Reaffirms 2025 Guidance, and Prepares to Announce Fragile X Trial Data in Q3 - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Reaffirms FY25 Revenue View at $820M-$860M - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony targets $1B+ WAKIX sales in narcolepsy as late-stage pipeline advances - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Reports Q2 2025 Earnings: Revenue Up 16% - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Three Stocks to Buy Now: Harmony Biosciences, Syndax Pharmaceuticals, and Viper Energy - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 - BioSpace

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings, Inc. (HRMY): A Bullish Thesis on Strong Financials and Diversified Pipeline - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Inc (HRMY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Harmony Biosciences Holdings Inc (HRMY) Q2 2025 Earnings Call Hi - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus

Aug 06, 2025
pulisher
Aug 05, 2025

Harmony Biosciences' Q2 2025: Unraveling Contradictions in ZYN002 and WAKIX Strategies - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Holdings, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:HRMY) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Transcript : Harmony Biosciences Holdings, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Harmony Biosciences Q2 2025 beats EPS expectations - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Holdings: Strong Patient Growth and Promising Pipeline Support Buy Rating - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences falls as Q2 revenue misses estimates despite profit beat - Investing.com Nigeria

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Why Harmony Biosciences Holdings Inc. stock attracts strong analyst attentionSafe Entry Stock Watch Suggestions for Cautious Traders - beatles.ru

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Q2 2025 slides: revenue up 16% as WAKIX nears blockbuster status - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

Topline Data from the Phase 3 registrational trial of ZYN002 in Fragile X syndrome on track for Q3 2025. - Placera.se

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences : HRMY Q2 2025 Earnings Presentation FINAL - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 | HRMY Stock - GuruFocus

Aug 05, 2025
pulisher
Aug 04, 2025

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - Insider Monkey

Aug 04, 2025
pulisher
Aug 04, 2025

Harmony Biosciences Holdings Inc. Stages Intraday Comeback — Trend ChangeSecure Portfolio Growth Plan Review - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Harmony Biosciences Holdings Inc (HRMY) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

Trading Bots Trigger Alerts on Harmony Biosciences Holdings Inc. ActivityMassive Profit Potential - beatles.ru

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 07:58:17 - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

Is Harmony Biosciences Holdings Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Harmony Biosciences Holdings Inc. in the next 12 monthsAchieve consistent double-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Harmony Biosciences Holdings Inc. stock attracting strong analyst attentionUnlock your trading potential with expert tips - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Harmony Biosciences Holdings Inc. stock higher in 2025 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Harmony Biosciences Holdings Inc. Stock Analysis and ForecastTriple-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Harmony Biosciences Holdings Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Harmony Biosciences Holdings Inc. stock price move sharplyGrow your wealth steadily and securely - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Harmony Biosciences Holdings Inc. stock expected to show significant growthRapid capital growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for Harmony Biosciences Holdings Inc.Phenomenal trading returns - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Should I hold or sell Harmony Biosciences Holdings Inc. stock in 2025Invest smarter with real-time trading signals - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Harmony Biosciences to Release Q2 2025 Financial Results on August 5, 2025, Before Market Open - AInvest

Aug 02, 2025
pulisher
Aug 02, 2025

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance

Aug 02, 2025
pulisher
Aug 02, 2025

Harmony Biosciences Holdings' ROE and Earnings Growth: A Comprehensive Analysis - AInvest

Aug 02, 2025
pulisher
Jul 31, 2025

Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st

Jul 31, 2025
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Kapitalisierung:     |  Volumen (24h):